Literature DB >> 14533000

N-3 fatty acid-rich diet prevents early response of interleukin-6 elevation in trinitrobenzene sulfonic acid-induced enteritis.

Akira Andoh1, Tomoyuki Tsujikawa, Izumi Ishizuka, Yoshio Araki, Masaya Sasaki, Shigeki Koyama, Yoshihide Fujiyama.   

Abstract

Dietary fat is an important factor involved in the pathogenesis of inflammatory bowel disease (IBD). It remains unclear how n-3 and n-6 fatty acids modulate intestinal inflammation. In this study, we investigated the effects of n-3 and n-6 fatty acid-rich diets on trinitrobenzene sulfonic acid (TNBS)-induced enteritis. The rats were fed an n-3 or n-6 rich-diet for 12 days, and then starved for the following 2 days. An intraileal injection of TNBS was administered, and TNBS-enteritis subsequently developed. Macroscopic and histological examination was performed after 24 h. Serum cytokine levels were determined by ELISA. The n-6 fatty acid-rich diet markedly enhanced mucosal damage as compared to the n-3 fatty acid-rich diet. The damage score was significantly higher in the n-6 fatty acid-rich diet group (P<0.05). Histological changes in the mucosa were more severe in the n-6 fatty acid-rich diet group than in the n-3 fatty acid-rich group. Serum IL-6 levels were significantly higher in the n-6 fatty acid-rich diet group than in the n-3 fatty acid-rich group (P<0.05). On the other hand, there were no differences in serum TNF-alpha levels. The n-3 fatty acid-rich diet effectively reduced early mucosal inflammation in TNBS enteritis. The effects of the n-3 fatty acids were associated with blockage of mucosal IL-6 secretion. Our data suggest that n-3 fatty acid-rich diet may be applicable for enteral nutrition in the treatment of IBD patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14533000

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  13 in total

1.  2,4,6-trinitrobenzene sulfonic acid-induced chronic colitis with fibrosis and modulation of TGF-β1 signaling.

Authors:  Emilien Loeuillard; Julien Bertrand; Anni Herranen; Chloé Melchior; Charlène Guérin; Moïse Coëffier; Moutaz Aziz; Pierre Déchelotte; Guillaume Savoye; Rachel Marion-Letellier
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

2.  DNBS/TNBS colitis models: providing insights into inflammatory bowel disease and effects of dietary fat.

Authors:  Vijay Morampudi; Ganive Bhinder; Xiujuan Wu; Chuanbin Dai; Ho Pan Sham; Bruce A Vallance; Kevan Jacobson
Journal:  J Vis Exp       Date:  2014-02-27       Impact factor: 1.355

3.  Treatment with Mesna and n-3 polyunsaturated fatty acids ameliorates experimental ulcerative colitis in rats.

Authors:  Ioannis Triantafyllidis; Theofilos Poutahidis; Ioannis Taitzoglou; Isaak Kesisoglou; Charalampos Lazaridis; Dimitrios Botsios
Journal:  Int J Exp Pathol       Date:  2016-01-19       Impact factor: 1.925

Review 4.  The potential interactions between polyunsaturated fatty acids and colonic inflammatory processes.

Authors:  S C Mills; A C Windsor; S C Knight
Journal:  Clin Exp Immunol       Date:  2005-11       Impact factor: 4.330

5.  Oral treatment with genistein reduces the expression of molecular and biochemical markers of inflammation in a rat model of chronic TNBS-induced colitis.

Authors:  Jan Seibel; Almut F Molzberger; Torsten Hertrampf; Ute Laudenbach-Leschowski; Patrick Diel
Journal:  Eur J Nutr       Date:  2009-02-21       Impact factor: 5.614

6.  Omega-3 fatty acids in the maintenance of ulcerative colitis.

Authors:  Cinzia Papadia; Alessandro Coruzzi; Chiara Montana; Francesco Di Mario; Angelo Franzè; Alastair Forbes
Journal:  JRSM Short Rep       Date:  2010-06-30

7.  Nutritional Therapy in Inflammatory Bowel Disease.

Authors:  Maria O'Sullivan; Colm O'Morain
Journal:  Curr Treat Options Gastroenterol       Date:  2004-06

8.  Omega-3 and omega-6 PUFAs induce the same GPR120-mediated signalling events, but with different kinetics and intensity in Caco-2 cells.

Authors:  Kaia Mobraten; Trude M Haug; Charlotte R Kleiveland; Tor Lea
Journal:  Lipids Health Dis       Date:  2013-07-13       Impact factor: 3.876

Review 9.  Changing incidence of inflammatory bowel disease: environmental influences and lessons learnt from the South asian population.

Authors:  Alice Foster; Kevan Jacobson
Journal:  Front Pediatr       Date:  2013-11-06       Impact factor: 3.418

10.  Fish oil attenuates omega-6 polyunsaturated fatty acid-induced dysbiosis and infectious colitis but impairs LPS dephosphorylation activity causing sepsis.

Authors:  Sanjoy Ghosh; Daniella DeCoffe; Kirsty Brown; Ethendhar Rajendiran; Mehrbod Estaki; Chuanbin Dai; Ashley Yip; Deanna L Gibson
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.